Ledger.Open graph →
SEC Form D · filed September 17, 2020

Palleon Pharmaceuticals Inc

Offering
$100.0M
Sold
$100.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

James W. Broderick · Waltham, MAExec · DirectorStephen W. Hoffman · Waltham, MADirectorJohn W. Hennessy · Waltham, MAExecWilliam W. Burkoth · Waltham, MADirectorKaran W. Takhar · Waltham, MADirectorRajeev W. Dadoo · Waltham, MADirectorEric W. Xiao · Waltham, MADirectorFrank I. Dilazzaro · San Antonio, TXDirectorCharles I. Biltz, Jr · San Antonio, TXExec · DirectorSilbiano V. Gonzales, Jr · San Antonio, TXDirectorMichael V. Morykwas · San Antonio, TXExecCAVU Management LP · Fort Worth, TXExecCharles Tollinche · Chicago, ILExec · DirectorRobert G. Walton · Chicago, ILDirectorPatrick G. Fenton · Chicago, ILDirectorKaran W. Takhar · Waltham, MADirectorRajeev W. Dadoo · Waltham, MADirectorEric W. Xiao · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗